Efficacy of antiviral therapy in patients with post-hepatitis C liver cirrhosis: is hyperuricaemia a potential adverse effect?

Hepatitis C virus (HCV) related liver cirrhosis is considered a major health problem; sofosbuvir (SOF)/ledipasvir (LDV) and SOF/daclatsvir (DACLA) are very promising direct antiviral agents (DAAS) especially in treating HCV genotype 4 which is the main genotype in Egypt. Uric acid elevation was repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsayed, Amr, M Abdelraheem, Ehab, Hassan, Hatem, Abbas, Abbas, Hassnine, Alshymaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735097/
https://www.ncbi.nlm.nih.gov/pubmed/33310750
http://dx.doi.org/10.1136/bmjgast-2020-000533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735097/
https://www.ncbi.nlm.nih.gov/pubmed/33310750
http://dx.doi.org/10.1136/bmjgast-2020-000533

Ejemplares similares